These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7846411)

  • 21. Cellular immune response to human immunodeficiency virus.
    Norris PJ; Rosenberg ES
    AIDS; 2001 Feb; 15 Suppl 2():S16-21. PubMed ID: 11424972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys.
    Barouch DH; Fu TM; Montefiori DC; Lewis MG; Shiver JW; Letvin NL
    Immunol Lett; 2001 Nov; 79(1-2):57-61. PubMed ID: 11595290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling HIV concentration during acute AIDS infection.
    Wilson SE; Habeshaw JA; Oxford JS
    Science; 1996 Jun; 272(5270):1960-2. PubMed ID: 8658173
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV infection and rheumatic diseases--autoimmune mechanisms in immunodeficient hosts.
    Weyand CM; Goronzy JJ
    Z Rheumatol; 1992; 51(2):55-64. PubMed ID: 1535472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting who will progress to AIDS.
    Moss AR
    BMJ; 1988 Oct; 297(6656):1067-8. PubMed ID: 2973821
    [No Abstract]   [Full Text] [Related]  

  • 26. [Impairment of the immune system by HIV infection].
    Arndt R; Keeser D
    Z Hautkr; 1989 May; 64(5):353-4, 357-8, 363. PubMed ID: 2525849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
    Rosenberg ES; Billingsley JM; Caliendo AM; Boswell SL; Sax PE; Kalams SA; Walker BD
    Science; 1997 Nov; 278(5342):1447-50. PubMed ID: 9367954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TFH in HIV Latency and as Sources of Replication-Competent Virus.
    Miles B; Connick E
    Trends Microbiol; 2016 May; 24(5):338-344. PubMed ID: 26947191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The programmed cell death theory of AIDS pathogenesis: implications, testable predictions, and confrontation with experimental findings.
    Ameisen JC
    Immunodefic Rev; 1992; 3(3):237-46. PubMed ID: 1354969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunopathogenesis of HIV infection].
    Alcamí J; Coiras M
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):216-26. PubMed ID: 21388715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of absolute T helper cell number and cellular immune defects in HIV antibody positive and negative homosexual men.
    Creemers PC; O'Shaughnessy M; Boyko WJ
    AIDS Res Hum Retroviruses; 1988 Aug; 4(4):269-78. PubMed ID: 2974709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs.
    Bailey J; Blankson JN; Wind-Rotolo M; Siliciano RF
    Curr Opin Immunol; 2004 Aug; 16(4):470-6. PubMed ID: 15245741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calculation and use of an HIV-1 disease progression score.
    Roussanov BV; Taylor JM; Giorgi JV
    AIDS; 2000 Dec; 14(17):2715-22. PubMed ID: 11125890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection.
    Müller V; Vigueras-Gómez JF; Bonhoeffer S
    J Virol; 2002 Sep; 76(17):8963-5. PubMed ID: 12163616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune stimulation and HIV-1 viral replication.
    Wahl SM; Orenstein JM
    J Leukoc Biol; 1997 Jul; 62(1):67-71. PubMed ID: 9225995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virus.
    Yoffe B; Lewis DE; Petrie BL; Noonan CA; Melnick JL; Hollinger FB
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1429-33. PubMed ID: 2950525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AIDS: decline and fall of immune surveillance?
    Feinberg MB; McLean AR
    Curr Biol; 1997 Mar; 7(3):R136-40. PubMed ID: 9162473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the care of children and adolescents with HIV infection. Immunologic considerations in pediatric HIV infection.
    Wade N
    J Pediatr; 1991 Jul; 119(1 Pt 2):S5-7. PubMed ID: 2061758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.